TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2737618
log Bayes Factor = <0.0001
Chromosome 1   position 200,107,425  (GRCh37) Explore rs2737618 on Ensembl!
Variant rs2737618 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
N50.1 Vascular disorders of male genital organs
0.000 0.960 0.040
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.036 0.964 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.018 0.982 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.014 0.986 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.013 0.987 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.013 0.987 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.013 0.987 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.013 0.987 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.013 0.987 0.000
Y51.0 Anticholinesterase agents
0.013 0.987 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.013 0.987 0.000
Y85.0 Sequelae of motor-vehicle accident
0.009 0.991 0.000
Y85.9 Sequelae of other and unspecified transport accidents
0.009 0.991 0.000
Y85 Sequelae of transport accidents
0.008 0.992 0.000
T78.2 Anaphylactic shock, unspecified
0.000 0.994 0.006
H02.3 Blepharochalasis
0.006 0.994 0.000
T78 Adverse effects, not elsewhere classified
0.000 0.994 0.006
T78.3 Angioneurotic oedema
0.000 0.994 0.006
F43.2 Adjustment disorders
0.005 0.995 0.000
K50.1 Crohn's disease of large intestine
0.005 0.995 0.000
T78.4 Allergy, unspecified
0.000 0.995 0.005
T78.0 Anaphylactic shock due to adverse food reaction
0.000 0.995 0.005
T78.8 Other adverse effects, not elsewhere classified
0.000 0.995 0.005
T78.9 Adverse effect, unspecified
0.000 0.995 0.004
S22.30 Fracture of rib (closed)
0.000 0.996 0.004
T78.1 Other adverse food reactions, not elsewhere classified
0.000 0.996 0.004
N50 Other disorders of male genital organs
0.000 0.996 0.004
O21.9 Vomiting of pregnancy, unspecified
0.004 0.996 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.000 0.996 0.004
T80.2 Infections following infusion, transfusion and therapeutic injection
0.004 0.996 0.000
E21.3 Hyperparathyroidism, unspecified
0.004 0.996 0.000
R81 Glycosuria
0.004 0.996 0.000
G37.9 Demyelinating disease of central nervous system, unspecified
0.004 0.996 0.000
M20.2 Hallux rigidus
0.004 0.996 0.000
J02.9 Acute pharyngitis, unspecified
0.000 0.996 0.004
L85.8 Other specified epidermal thickening
0.004 0.996 0.000
C77.1 Intrathoracic lymph nodes
0.004 0.996 0.000
N50.0 Atrophy of testis
0.000 0.997 0.003
R57.9 Shock, unspecified
0.003 0.997 0.000
O21.2 Late vomiting of pregnancy
0.003 0.997 0.000
O21 Excessive vomiting in pregnancy
0.003 0.997 0.000
N87.1 Moderate cervical dysplasia
0.000 0.997 0.003
O21.8 Other vomiting complicating pregnancy
0.003 0.997 0.000
T80 Complications following infusion, transfusion and therapeutic injection
0.003 0.997 0.000
F23 Acute and transient psychotic disorders
0.000 0.997 0.003
M11.26 Other chondrocalcinosis (Lower leg)
0.003 0.997 0.000
C71.1 Frontal lobe
0.000 0.997 0.003
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection
0.003 0.997 0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection
0.003 0.997 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.000 0.997 0.003
J38.1 Polyp of vocal cord and larynx
0.003 0.997 0.000
Z73.9 Problem related to life-management difficulty, unspecified
0.000 0.997 0.003
Z42.0 Follow-up care involving plastic surgery of head and neck
0.000 0.997 0.003
G70.0 Myasthenia gravis
0.003 0.997 0.000
N90.5 Atrophy of vulva
0.000 0.997 0.003
O21.1 Hyperemesis gravidarum with metabolic disturbance
0.002 0.997 0.000
R57.2 Septic shock
0.003 0.997 0.000
M25.86 Other specified joint disorders (Lower leg)
0.000 0.998 0.002
Q21.1 Atrial septal defect
0.002 0.998 0.000
F23.8 Other acute and transient psychotic disorders
0.000 0.998 0.002
F23.3 Other acute predominantly delusional psychotic disorders
0.000 0.998 0.002
F23.2 Acute schizophrenia-like psychotic disorder
0.000 0.998 0.002
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.000 0.998 0.002
T80.6 Other serum reactions
0.002 0.998 0.000
T80.5 Anaphylactic shock due to serum
0.002 0.998 0.000
T80.4 Rh incompatibility reaction
0.002 0.998 0.000
T80.3 ABO incompatibility reaction
0.002 0.998 0.000
T80.0 Air embolism following infusion, transfusion and therapeutic injection
0.002 0.998 0.000
T80.1 Vascular complications following infusion, transfusion and therapeutic injection
0.002 0.998 0.000
D14.0 Middle ear, nasal cavity and accessory sinuses
0.002 0.998 0.000
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome
0.000 0.998 0.002
J32.0 Chronic maxillary sinusitis
0.002 0.998 0.000
S02.70 Multiple fractures involving skull and facial bones (closed)
0.002 0.998 0.000
S22.3 Fracture of rib
0.000 0.998 0.002
L21.9 Seborrhoeic dermatitis, unspecified
0.002 0.998 0.000
R57 Shock, not elsewhere classified
0.002 0.998 0.000
A41.8 Other specified septicaemia
0.002 0.998 0.000
Y54.7 Agents affecting calcification
0.002 0.998 0.000
M13.09 Polyarthritis, unspecified (Site unspecified)
0.000 0.998 0.002
N50.9 Disorder of male genital organs, unspecified
0.000 0.998 0.002
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system
0.002 0.998 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.002 0.998 0.000
Y40.3 Macrolides
0.002 0.998 0.000
F32.0 Mild depressive episode
0.002 0.998 0.000
F43 Reaction to severe stress, and adjustment disorders
0.002 0.998 0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.002 0.998 0.000
D80.1 Nonfamilial hypogammaglobulinaemia
0.002 0.998 0.000
F33.1 Recurrent depressive disorder, current episode moderate
0.002 0.998 0.000
R57.0 Cardiogenic shock
0.002 0.998 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
D48.0 Bone and articular cartilage
0.002 0.998 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.002 0.998 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.002 0.998 0.000
M79.09 Rheumatism, unspecified (Site unspecified)
0.000 0.998 0.002
J95.8 Other postprocedural respiratory disorders
0.002 0.998 0.000
Y49.5 Other antipsychotics and neuroleptics
0.002 0.998 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.002 0.998 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.002 0.998 0.000
I67.1 Cerebral aneurysm, nonruptured
0.002 0.998 0.000
X42.2 School, other institution and public administrative area
0.002 0.998 0.000
O21.0 Mild hyperemesis gravidarum
0.002 0.998 0.000
O41.8 Other specified disorders of amniotic fluid and membranes
0.000 0.998 0.002
Q18.1 Preauricular sinus and cyst
0.000 0.998 0.002
Y54.5 Other diuretics
0.002 0.998 0.000
S22.31 Fracture of rib (open)
0.000 0.998 0.002
F43.9 Reaction to severe stress, unspecified
0.002 0.998 0.000
I86.1 Scrotal varices
0.000 0.998 0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.002 0.998 0.000
Q28.2 Arteriovenous malformation of cerebral vessels
0.002 0.998 0.000
R57.8 Other shock
0.002 0.998 0.000
Y59.3 Immunoglobulin
0.002 0.998 0.000
T66-T78 Other and unspecified effects of external causes
0.000 0.998 0.002
Y49.2 Other and unspecified antidepressants
0.002 0.998 0.000
I86.4 Gastric varices
0.000 0.998 0.002
V89.2 Person injured in unspecified motor-vehicle accident, traffic
0.000 0.998 0.002
Y59 Other and unspecified vaccines and biological substances
0.002 0.998 0.000
F43.8 Other reactions to severe stress
0.002 0.998 0.000
Y40 Systemic antibiotics
0.002 0.998 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.002 0.998 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.002 0.998 0.000
G47.0 Disorders of initiating and maintaining sleep [insomnias]
0.002 0.998 0.000
F43.0 Acute stress reaction
0.002 0.998 0.000
O45.9 Premature separation of placenta, unspecified
0.000 0.998 0.002
E21.5 Disorder of parathyroid gland, unspecified
0.002 0.998 0.000
E21.4 Other specified disorders of parathyroid gland
0.002 0.998 0.000
Y40.9 Systemic antibiotic, unspecified
0.002 0.998 0.000
D28.0 Vulva
0.000 0.998 0.002
H53.4 Visual field defects
0.000 0.998 0.002
M11.2 Other chondrocalcinosis
0.002 0.998 0.000
Y55.4 Expectorants
0.002 0.998 0.000
D14.1 Larynx
0.002 0.998 0.000
G11.9 Hereditary ataxia, unspecified
0.002 0.998 0.000
I86.2 Pelvic varices
0.000 0.998 0.002
T75 Effects of other external causes
0.000 0.998 0.002
Y40.1 Cefalosporins and other -lactam antibiotics
0.002 0.998 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.998 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.998 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.998 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.998 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.998 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.998 0.000
R57.1 Hypovolaemic shock
0.002 0.998 0.000
Y40.6 Rifamycins
0.002 0.998 0.000
Y56.9 Topical agent, unspecified
0.002 0.998 0.000
Y56.8 Other topical agents
0.002 0.998 0.000
Y56.7 Dental drugs, topically applied
0.002 0.998 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.002 0.998 0.000
Y56.5 Ophthalmological drugs and preparations
0.002 0.998 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.002 0.998 0.000
Y56.3 Emollients, demulcents and protectants
0.002 0.998 0.000
Y56.2 Local astringents and local detergents
0.002 0.998 0.000
Y56.1 Antipruritics
0.002 0.998 0.000
Y54.9 Mineral salts, not elsewhere classified
0.002 0.998 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.002 0.998 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.002 0.998 0.000
Y54.0 Mineralocorticoids
0.002 0.998 0.000
T75.4 Effects of electric current
0.000 0.998 0.002
E61.1 Iron deficiency
0.000 0.998 0.002
F20.0 Paranoid schizophrenia
0.000 0.998 0.002
T24.3 Burn of third degree of hip and lower limb, except ankle and foot
0.002 0.998 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.002 0.998 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.002 0.998 0.000
Y55.5 Anticommon cold drugs
0.002 0.998 0.000
Y55.3 Antitussives
0.002 0.998 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.002 0.998 0.000
Y55.0 Oxytocic drugs
0.002 0.998 0.000
E21.0 Primary hyperparathyroidism
0.002 0.998 0.000
H02.5 Other disorders affecting eyelid function
0.002 0.998 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.002 0.998 0.000
G70.9 Myoneural disorder, unspecified
0.002 0.998 0.000
T74 Maltreatment syndromes
0.000 0.998 0.002
T73 Effects of other deprivation
0.000 0.998 0.002
T69 Other effects of reduced temperature
0.000 0.998 0.002
T67 Effects of heat and light
0.000 0.998 0.002
M11.21 Other chondrocalcinosis (Shoulder region)
0.002 0.998 0.000
T18.1 Foreign body in oesophagus
0.002 0.998 0.000
G70 Myasthenia gravis and other myoneural disorders
0.002 0.998 0.000
I86 Varicose veins of other sites
0.000 0.998 0.002
Y53 Agents primarily affecting the gastro-intestinal system
0.002 0.998 0.000
I77.1 Stricture of artery
0.002 0.998 0.000
X41.9 Unspecified place
0.002 0.998 0.000
Y40.2 Chloramphenicol group
0.001 0.998 0.000
Y59.9 Vaccine or biological substance, unspecified
0.001 0.998 0.000
Y59.8 Other specified vaccines and biological substances
0.001 0.998 0.000
Y59.2 Protozoal vaccines
0.001 0.998 0.000
Y59.1 Rickettsial vaccines
0.001 0.998 0.000
Y59.0 Viral vaccines
0.001 0.998 0.000
T68 Hypothermia
0.000 0.998 0.002
H02.8 Other specified disorders of eyelid
0.002 0.998 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.002 0.998 0.000
Y54.8 Agents affecting uric acid metabolism
0.001 0.998 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.001 0.998 0.000
E21.2 Other hyperparathyroidism
0.001 0.998 0.000
S20.8 Superficial injuries of other and unspecified parts of thorax
0.000 0.998 0.002
M65.86 Other synovitis and tenosynovitis (Lower leg)
0.000 0.998 0.002
Y40.5 Aminoglycosides
0.001 0.998 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.001 0.998 0.000
Q21 Congenital malformations of cardiac septa
0.002 0.998 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.001 0.998 0.000
M11.29 Other chondrocalcinosis (Site unspecified)
0.001 0.998 0.000
M11.28 Other chondrocalcinosis (Other)
0.001 0.998 0.000
M11.27 Other chondrocalcinosis (Ankle and foot)
0.001 0.998 0.000
M11.25 Other chondrocalcinosis (Pelvic region and thigh)
0.001 0.998 0.000
M11.24 Other chondrocalcinosis (Hand)
0.001 0.998 0.000
M11.23 Other chondrocalcinosis (Forearm)
0.001 0.998 0.000
M11.22 Other chondrocalcinosis (Upper arm)
0.001 0.998 0.000
M11.20 Other chondrocalcinosis (Multiple sites)
0.001 0.998 0.000
S02.50 Fracture of tooth (closed)
0.002 0.998 0.000
Y40.7 Antifungal antibiotics, systemically used
0.001 0.998 0.000
Y54.3 Benzothiadiazine derivatives
0.001 0.998 0.000
T66 Unspecified effects of radiation
0.000 0.998 0.001
D28.1 Vagina
0.000 0.998 0.001
H66.3 Other chronic suppurative otitis media
0.002 0.998 0.000
T75.8 Other specified effects of external causes
0.000 0.998 0.001
T75.3 Motion sickness
0.000 0.998 0.001
T75.2 Effects of vibration
0.000 0.998 0.001
T75.0 Effects of lightning
0.000 0.998 0.001
Y53.1 Other antacids and anti-gastric-secretion drugs
0.001 0.998 0.000
Y54.4 Loop [high-ceiling] diuretics
0.001 0.998 0.000
T71 Asphyxiation
0.000 0.998 0.001
F79.9 Unspecified mental retardation (Without mention of impairment of behaviour)
0.001 0.998 0.000
S20.2 Contusion of thorax
0.000 0.998 0.002
Q21.9 Congenital malformation of cardiac septum, unspecified
0.001 0.998 0.000
Q85.0 Neurofibromatosis (nonmalignant)
0.001 0.998 0.000
Y58 Bacterial vaccines
0.001 0.998 0.000
T67.9 Effects of heat and light, unspecified
0.000 0.999 0.001
T67.8 Other effects of heat and light
0.000 0.999 0.001
T67.7 Heat oedema
0.000 0.999 0.001
T67.6 Heat fatigue, transient
0.000 0.999 0.001
T67.5 Heat exhaustion, unspecified
0.000 0.999 0.001
T67.4 Heat exhaustion due to salt depletion
0.000 0.999 0.001
T67.3 Heat exhaustion, anhydrotic
0.000 0.999 0.001
T67.2 Heat cramp
0.000 0.999 0.001
T67.1 Heat syncope
0.000 0.999 0.001
T67.0 Heatstroke and sunstroke
0.000 0.999 0.001
T69.9 Effect of reduced temperature, unspecified
0.000 0.999 0.001
T69.8 Other specified effects of reduced temperature
0.000 0.999 0.001
T69.1 Chilblains
0.000 0.999 0.001
T69.0 Immersion hand and foot
0.000 0.999 0.001
T73.9 Effect of deprivation, unspecified
0.000 0.999 0.001
T73.8 Other effects of deprivation
0.000 0.999 0.001
T73.3 Exhaustion due to excessive exertion
0.000 0.999 0.001
T73.2 Exhaustion due to exposure
0.000 0.999 0.001
T73.1 Effects of thirst
0.000 0.999 0.001
T73.0 Effects of hunger
0.000 0.999 0.001
T74.9 Maltreatment syndrome, unspecified
0.000 0.999 0.001
T74.8 Other maltreatment syndromes
0.000 0.999 0.001
T74.3 Psychological abuse
0.000 0.999 0.001
T74.2 Sexual abuse
0.000 0.999 0.001
T74.1 Physical abuse
0.000 0.999 0.001
T74.0 Neglect or abandonment
0.000 0.999 0.001
D14 Benign neoplasm of middle ear and respiratory system
0.001 0.999 0.000
T70 Effects of air pressure and water pressure
0.000 0.999 0.001
X42 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.001 0.999 0.000
H02.6 Xanthelasma of eyelid
0.001 0.999 0.000
T75.1 Drowning and nonfatal submersion
0.000 0.999 0.001
G70.8 Other specified myoneural disorders
0.001 0.999 0.000
G70.2 Congenital and developmental myasthenia
0.001 0.999 0.000
G70.1 Toxic myoneural disorders
0.001 0.999 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.000 0.999 0.001
I86.0 Sublingual varices
0.000 0.999 0.001
N85.2 Hypertrophy of uterus
0.001 0.999 0.000
Y46.2 Hydantoin derivatives
0.001 0.999 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.001 0.999 0.000
Y53.7 Emetics
0.001 0.999 0.000
Y53.6 Antidiarrhoeal drugs
0.001 0.999 0.000
Y53.5 Digestants
0.001 0.999 0.000
Y53.3 Saline and osmotic laxatives
0.001 0.999 0.000
Y53.2 Stimulant laxatives
0.001 0.999 0.000
Y53.0 Histamine H2-receptor antagonists
0.001 0.999 0.000
H02 Other disorders of eyelid
0.001 0.999 0.000
I45.6 Preexcitation syndrome
0.001 0.999 0.000
G11 Hereditary ataxia
0.001 0.999 0.000
G11.4 Hereditary spastic paraplegia
0.001 0.999 0.000
K63.9 Disease of intestine, unspecified
0.001 0.999 0.000
O04.4 Incomplete, without complication
0.000 0.999 0.001
Y40.4 Tetracyclines
0.001 0.999 0.000
Y50.9 Central nervous system stimulant, unspecified
0.001 0.999 0.000
Y50.8 Other central nervous system stimulants
0.001 0.999 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.001 0.999 0.000
Y50.1 Opioid receptor antagonists
0.001 0.999 0.000
Y50.0 Analeptics
0.001 0.999 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.001 0.999 0.000
C44.2 Skin of ear and external auricular canal
0.000 0.999 0.001
D28.2 Uterine tubes and ligaments
0.000 0.999 0.001
F60.9 Personality disorder, unspecified
0.001 0.999 0.000
I86.3 Vulval varices
0.000 0.999 0.001
O69.1 Labour and delivery complicated by cord around neck, with compression
0.000 0.999 0.001
Q21.8 Other congenital malformations of cardiac septa
0.001 0.999 0.000
Q21.4 Aortopulmonary septal defect
0.001 0.999 0.000
Q21.2 Atrioventricular septal defect
0.001 0.999 0.000
R82.8 Abnormal findings on cytological and histological examination of urine
0.001 0.999 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.001 0.999 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.001 0.999 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.001 0.999 0.000
Y47.4 Bromine compounds
0.001 0.999 0.000
Y47.3 Paraldehyde
0.001 0.999 0.000
Y47.2 Chloral derivatives
0.001 0.999 0.000
Y47.0 Barbiturates, not elsewhere classified
0.001 0.999 0.000
F20 Schizophrenia
0.000 0.999 0.001
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.001 0.999 0.000
H02.2 Lagophthalmos
0.001 0.999 0.000
M17.0 Primary gonarthrosis, bilateral
0.001 0.999 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.001 0.999 0.000
M84.16 Nonunion of fracture [pseudarthrosis] (Lower leg)
0.000 0.999 0.001
D80.4 Selective deficiency of immunoglobulin M [IgM]
0.001 0.999 0.000
F20.9 Schizophrenia, unspecified
0.000 0.999 0.001
G45.8 Other transient cerebral ischaemic attacks and related syndromes
0.000 0.999 0.001
Q21.3 Tetralogy of Fallot
0.001 0.999 0.000
Y47.1 Benzodiazepines
0.001 0.999 0.000
H21.2 Degeneration of iris and ciliary body
0.001 0.999 0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.000 0.999 0.001
I86.8 Varicose veins of other specified sites
0.000 0.999 0.001
J01.9 Acute sinusitis, unspecified
0.001 0.999 0.000
J11.1 Influenza with other respiratory manifestations, virus not identified
0.001 0.999 0.000
D28 Benign neoplasm of other and unspecified female genital organs
0.000 0.999 0.001
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.001 0.999 0.000
D14.4 Respiratory system, unspecified
0.001 0.999 0.000
D14.2 Trachea
0.001 0.999 0.000
T70.9 Effect of air pressure and water pressure, unspecified
0.000 0.999 0.001
T70.8 Other effects of air pressure and water pressure
0.000 0.999 0.001
T70.4 Effects of high-pressure fluids
0.000 0.999 0.001
T70.2 Other and unspecified effects of high altitude
0.000 0.999 0.001
T70.1 Sinus barotrauma
0.000 0.999 0.001
T70.0 Otitic barotrauma
0.000 0.999 0.001
V04.1 Traffic accident
0.001 0.999 0.000
X42.9 Unspecified place
0.001 0.999 0.000
X42.0 Home
0.001 0.999 0.000
X42.8 Other specified place
0.001 0.999 0.000
X42.7 Farm
0.001 0.999 0.000
X42.6 Industrial and construction area
0.001 0.999 0.000
X42.5 Trade and service area
0.001 0.999 0.000
X42.4 Street and highway
0.001 0.999 0.000
X42.3 Sports and athletics area
0.001 0.999 0.000
X42.1 Residential institution
0.001 0.999 0.000
Y58.9 Other and unspecified bacterial vaccines
0.001 0.999 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.001 0.999 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.001 0.999 0.000
Y58.5 Diphtheria vaccine
0.001 0.999 0.000
Y58.4 Tetanus vaccine
0.001 0.999 0.000
Y58.3 Plague vaccine
0.001 0.999 0.000
Y58.2 Cholera vaccine
0.001 0.999 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.001 0.999 0.000
Q28 Other congenital malformations of circulatory system
0.001 0.999 0.000
S52.80 Fracture of other parts of forearm (closed)
0.001 0.999 0.000
F43.1 Posttraumatic stress disorder
0.001 0.999 0.000
G11.1 Early-onset cerebellar ataxia
0.001 0.999 0.000
T18.9 Foreign body in alimentary tract, part unspecified
0.001 0.999 0.000
X41.2 School, other institution and public administrative area
0.001 0.999 0.000
G11.8 Other hereditary ataxias
0.001 0.999 0.000
G11.3 Cerebellar ataxia with defective DNA repair
0.001 0.999 0.000
G11.2 Late-onset cerebellar ataxia
0.001 0.999 0.000
G11.0 Congenital nonprogressive ataxia
0.001 0.999 0.000
H02.7 Other degenerative disorders of eyelid and periocular area
0.001 0.999 0.000
K63.8 Other specified diseases of intestine
0.001 0.999 0.000
T18.3 Foreign body in small intestine
0.001 0.999 0.000
S42.00 Fracture of clavicle (closed)
0.001 0.999 0.000
F41.2 Mixed anxiety and depressive disorder
0.000 0.999 0.001
G12.2 Motor neuron disease
0.001 0.999 0.000
H11.8 Other specified disorders of conjunctiva
0.000 0.999 0.001
W55.0 Home
0.000 0.999 0.001
Y40.0 Penicillins
0.001 0.999 0.000
Y46.8 Antispasticity drugs
0.001 0.999 0.000
Y46.5 Valproic acid
0.001 0.999 0.000
Y46.3 Deoxybarbiturates
0.001 0.999 0.000
Y46.1 Oxazolidinediones
0.001 0.999 0.000
Y46.0 Succinimides
0.001 0.999 0.000
F20.8 Other schizophrenia
0.000 0.999 0.001
F20.6 Simple schizophrenia
0.000 0.999 0.001
F20.4 Postschizophrenic depression
0.000 0.999 0.001
F20.3 Undifferentiated schizophrenia
0.000 0.999 0.001
F20.2 Catatonic schizophrenia
0.000 0.999 0.001
F20.1 Hebephrenic schizophrenia
0.000 0.999 0.001
K12.2 Cellulitis and abscess of mouth
0.000 0.999 0.001
K45.8 Other specified abdominal hernia without obstruction or gangrene
0.001 0.999 0.000
S20.3 Other superficial injuries of front wall of thorax
0.000 0.999 0.001
J02 Acute pharyngitis
0.000 0.999 0.001
T18 Foreign body in alimentary tract
0.001 0.999 0.000
K26.7 Chronic without haemorrhage or perforation
0.001 0.999 0.000
M21.47 Flat foot [pes planus] (acquired)-Ankle/foot
0.000 0.999 0.001
D28.9 Female genital organ, unspecified
0.000 0.999 0.001
D28.7 Other specified female genital organs
0.000 0.999 0.001
H66.1 Chronic tubotympanic suppurative otitis media
0.001 0.999 0.000
Q28.9 Congenital malformation of circulatory system, unspecified
0.001 0.999 0.000
Q28.8 Other specified congenital malformations of circulatory system
0.001 0.999 0.000
Q28.1 Other malformations of precerebral vessels
0.001 0.999 0.000
S20.0 Contusion of breast
0.000 0.999 0.001
X41.0 Home
0.001 0.999 0.000
X41.8 Other specified place
0.001 0.999 0.000
X41.7 Farm
0.001 0.999 0.000
X41.6 Industrial and construction area
0.001 0.999 0.000
X41.5 Trade and service area
0.001 0.999 0.000
X41.4 Street and highway
0.001 0.999 0.000
X41.3 Sports and athletics area
0.001 0.999 0.000
X41.1 Residential institution
0.001 0.999 0.000
Z97.4 Presence of external hearing-aid
0.000 0.999 0.001
M66.47 Spontaneous rupture of other tendons (Ankle and foot)
0.000 0.999 0.001
S62.00 Fracture of navicular [scaphoid] bone of hand (closed)
0.001 0.999 0.000
X42.08 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified,Home , While engaged in other specified activities
0.001 0.999 0.000
X42.99 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified; Unspecified place ;During unspecified activity
0.001 0.999 0.000
X42.91 Accidental poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified; Unspecified place ;While engaged in leisure activity
0.001 0.999 0.000
K09.2 Other cysts of jaw
0.001 0.999 0.000
L93.0 Discoid lupus erythematosus
0.001 0.999 0.000
X00.0 Home
0.001 0.999 0.000
Y58.0 BCG vaccine
0.001 0.999 0.000
S20 Superficial injury of thorax
0.000 0.999 0.001
M25.85 Other specified joint disorders (Pelvic region and thigh)
0.000 0.999 0.001
A40.8 Other streptococcal septicaemia
0.000 0.999 0.001
E61.2 Magnesium deficiency
0.000 0.999 0.001
T18.0 Foreign body in mouth
0.001 0.999 0.000
Y53.4 Other laxatives
0.001 0.999 0.000
D80 Immunodeficiency with predominantly antibody defects
0.001 0.999 0.000
Q22.1 Congenital pulmonary valve stenosis
0.001 0.999 0.000
R70.0 Elevated erythrocyte sedimentation rate
0.001 0.999 0.000
R89.7 Abnormal histological findings
0.001 0.999 0.000
S02.7 Multiple fractures involving skull and facial bones
0.001 0.999 0.000
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot
0.001 0.999 0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts
0.001 0.999 0.000
U51.0 Not Previously admitted to a psyciatric hospital
0.001 0.999 0.000
Y42.5 Other oestrogens and progestogens
0.001 0.999 0.000
Y46.7 Anti-Parkinsonism drugs
0.001 0.999 0.000
Y46.6 Other and unspecified antiepileptics
0.001 0.999 0.000
C71.0 Cerebrum, except lobes and ventricles
0.000 0.999 0.001
F17.2 Dependence syndrome
0.000 0.999 0.001
F32.2 Severe depressive episode without psychotic symptoms
0.001 0.999 0.000
I70.2 Atherosclerosis of arteries of the extremities
0.001 0.999 0.000
K76.8 Other specified diseases of liver
0.000 0.999 0.001
Q28.3 Other malformations of cerebral vessels
0.001 0.999 0.000
Q28.0 Arteriovenous malformation of precerebral vessels
0.001 0.999 0.000
R47.1 Dysarthria and anarthria
0.001 0.999 0.000
T18.8 Foreign body in other and multiple parts of alimentary tract
0.001 0.999 0.000
T18.5 Foreign body in anus and rectum
0.001 0.999 0.000
T18.4 Foreign body in colon
0.001 0.999 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.000 0.999 0.001
X41.08 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified , Home ,While engaged in other specified activities
0.001 0.999 0.000
D14.3 Bronchus and lung
0.001 0.999 0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy
0.001 0.999 0.000
K74.6 Other and unspecified cirrhosis of liver
0.001 0.999 0.000
R89.0 Abnormal level of enzymes
0.001 0.999 0.000
T18.2 Foreign body in stomach
0.001 0.999 0.000
T70.3 Caisson disease [decompression sickness]
0.001 0.999 0.001
D80.8 Other immunodeficiencies with predominantly antibody defects
0.001 0.999 0.000
D80.7 Transient hypogammaglobulinaemia of infancy
0.001 0.999 0.000
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia
0.001 0.999 0.000
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]
0.001 0.999 0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses
0.001 0.999 0.000
D80.0 Hereditary hypogammaglobulinaemia
0.001 0.999 0.000
F10.2 Dependence syndrome
0.000 0.999 0.001
X49.6 Industrial and construction area
0.001 0.999 0.000
S02.71 Multiple fractures involving skull and facial bones (open)
0.001 0.999 0.000
D03.5 Melanoma in situ of trunk
0.001 0.999 0.000
S01.4 Open wound of cheek and temporomandibular area
0.001 0.999 0.000
W51.9 Unspecified place
0.001 0.999 0.000
C71 Malignant neoplasm of brain
0.000 0.999 0.001
G37 Other demyelinating diseases of central nervous system
0.001 0.999 0.000
K50 Crohn's disease [regional enteritis]
0.001 0.999 0.000
A49.9 Bacterial infection, unspecified
0.001 0.999 0.000
H74.1 Adhesive middle ear disease
0.001 0.999 0.000
J02.8 Acute pharyngitis due to other specified organisms
0.000 0.999 0.001
J17.0 Pneumonia in bacterial diseases classified elsewhere
0.000 0.999 0.001
Q21.0 Ventricular septal defect
0.001 0.999 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.001 0.999 0.000
Z11.0 Special screening examination for intestinal infectious diseases
0.000 0.999 0.001
F28 Other nonorganic psychotic disorders
0.000 0.999 0.001
F24 Induced delusional disorder
0.000 0.999 0.001
F21 Schizotypal disorder
0.000 0.999 0.001
Y48 Anaesthetics and therapeutic gases
0.001 0.999 0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified
0.001 0.999 0.000
F22.9 Persistent delusional disorder, unspecified
0.000 0.999 0.001
H21.5 Other adhesions and disruptions of iris and ciliary body
0.001 0.999 0.000
H66.4 Suppurative otitis media, unspecified
0.001 0.999 0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae
0.000 0.999 0.001
N11.9 Chronic tubulo-interstitial nephritis, unspecified
0.000 0.999 0.001
S20.7 Multiple superficial injuries of thorax
0.000 0.999 0.001
F22 Persistent delusional disorders
0.000 0.999 0.001
G12 Spinal muscular atrophy and related syndromes
0.001 0.999 0.000
L21 Seborrhoeic dermatitis
0.001 0.999 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.001 0.999 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.001 0.999 0.000
C71.6 Cerebellum
0.000 0.999 0.001
C71.5 Cerebral ventricle
0.000 0.999 0.001
F20.5 Residual schizophrenia
0.000 0.999 0.001
G37.5 Concentric sclerosis [Balo]
0.001 0.999 0.000
G37.4 Subacute necrotising myelitis
0.001 0.999 0.000
G37.2 Central pontine myelinolysis
0.001 0.999 0.000
G37.1 Central demyelination of corpus callosum
0.001 0.999 0.000
G37.0 Diffuse sclerosis
0.001 0.999 0.000
J92.0 Pleural plaque with presence of asbestos
0.000 0.999 0.001
R89.5 Abnormal microbiological findings
0.001 0.999 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.001 0.999 0.000
Y44 Agents primarily affecting blood constituents
0.001 0.999 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.001 0.999 0.000
E24.9 Cushing's syndrome, unspecified
0.001 0.999 0.000
F22.8 Other persistent delusional disorders
0.000 0.999 0.001
G12.9 Spinal muscular atrophy, unspecified
0.001 0.999 0.000
G12.8 Other spinal muscular atrophies and related syndromes
0.001 0.999 0.000
G12.1 Other inherited spinal muscular atrophy
0.001 0.999 0.000
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.